METAFORA receives exceptional reimbursement for its new blood test METAglut1
avril 11, 2018
Metafora biosystems receives exceptional reimbursement for new blood test to help diagnose De Vivo disease
METAglut1 test enables early detection of this rare under-diagnosed disease
A 30-month long study will be carried out on 3,000 patients in 60 centers across France.